FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is intended for the continuous monitoring of blood sugar levels and glucose trends in…
AAP ·